Academic literature on the topic 'Intravenous fluid'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Intravenous fluid.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Intravenous fluid"
Kumar, Gautam, Ellie Walker, and Robert Stephens. "Intravenous fluid therapy." Trends in Anaesthesia and Critical Care 4, no. 2-3 (June 2014): 55–59. http://dx.doi.org/10.1016/j.tacc.2014.04.005.
Full textLassen, K. "Intravenous fluid therapy." British Journal of Surgery 96, no. 2 (February 2009): 123–24. http://dx.doi.org/10.1002/bjs.6466.
Full textHoorn, Ewout J. "Intravenous fluids: balancing solutions." Journal of Nephrology 30, no. 4 (November 29, 2016): 485–92. http://dx.doi.org/10.1007/s40620-016-0363-9.
Full textBarlow, Ashley, Brooke Barlow, Nancy Tang, Bhavik M. Shah, and Amber E. King. "Intravenous Fluid Management in Critically Ill Adults: A Review." Critical Care Nurse 40, no. 6 (December 1, 2020): e17-e27. http://dx.doi.org/10.4037/ccn2020337.
Full textSiddiqui, Aamir. "Intravenous Fluid Resuscitation: Breaking the Dilemma." Nepalese Medical Journal 1, no. 2 (December 2, 2018): 104–11. http://dx.doi.org/10.3126/nmj.v1i2.21625.
Full textAnthony, John, and Leann K. Schoeman. "Fluid management in pre-eclampsia." Obstetric Medicine 6, no. 3 (July 26, 2013): 100–104. http://dx.doi.org/10.1177/1753495x13486896.
Full textAlvarado Sánchez, Jorge Iván, William Fernando Amaya Zúñiga, and Manuel Ignacio Monge García. "Predictors to Intravenous Fluid Responsiveness." Journal of Intensive Care Medicine 33, no. 4 (May 16, 2017): 227–40. http://dx.doi.org/10.1177/0885066617709434.
Full textMathur, Abhinav, Gwen Johnston, and Laura Clark. "Improving intravenous fluid prescribing." Journal of the Royal College of Physicians of Edinburgh 50, no. 2 (June 2020): 181–87. http://dx.doi.org/10.4997/jrcpe.2020.224.
Full textLEWIS, F. R. "Prehospital Intravenous Fluid Therapy." Survey of Anesthesiology XXXI, no. 4 (August 1987): 218. http://dx.doi.org/10.1097/00132586-198708000-00026.
Full textRushton, A. M. "Therapeutics. Intravenous Fluid Therapy." British Journal of Anaesthesia 93, no. 5 (November 2004): 751. http://dx.doi.org/10.1093/bja/aeh628.
Full textDissertations / Theses on the topic "Intravenous fluid"
Neville, Kristen Ann Women's & Children's Health Faculty of Medicine UNSW. "Hyponatraemia and ADH secretion during intravenous fluid therapy in children." Awarded by:University of New South Wales. Women's & Children's Health, 2009. http://handle.unsw.edu.au/1959.4/44531.
Full textZalgaonker, Mustafa. "Intravenous fluid resuscitation : surveillance of penetrating injury in the pre-hospital environment." Thesis, Cape Peninsula University of Technology, 2018. http://hdl.handle.net/20.500.11838/2738.
Full textPhysical injury is a major cause of premature death and disability worldwide (WHO, 2015). Mortality statistics for South Africa indicate that approximately half of all injury-related deaths were intentionally inflicted, often as a result of sharp-force injuries (Donson 2009). Cape Town is reputed to be a violent city (Nicol et al., 2014). Pre-hospital emergency care providers are often the first medical contact for injured patients. Previously, it was understood that high volume crystalloid administration would improve survival and was standardised in the management of shock (Santry & Alam 2010). However, over-administration of crystalloid fluid can cause patient harm by potentially worsening injuries and can be detrimental to a patients survival. Current evidence supports the practice of lower volume crystalloid intravenous fluid administration- permissive hypotension. Little is known about pre-hospital emergency care providers intravenous fluid management practices for penetrating injury. Injury surveillance data for victims of penetrating injury is also scarce with the majority of current data taken from mortality sources. Surveilling pre-hospital cases may yield opportunities for prevention from premature mortality and morbidity. The aim of this study is to undertake surveillance of penetrating injury and related intravenous fluid resuscitation in the pre-hospital emergency care environment. A prospective observational descriptive survey was conducted in the Cape Metropole1. Over three consecutive months, emergency care providers documented parameters related to mechanism of injury, scene vital signs, hospital vital signs, intravenous fluid resuscitation and basic patient demographic information for patients with penetrating injury. A predetermined inclusion and exclusion criteria was used to sample patients.
Sjöstrand, Fredrik. "Volume kinetics of glucose solutions given by intravenous infusion /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-235-7/.
Full textVeldsman, Lizl. "The impact of intravenous fluid and electrolyte administration on total fluid, electrolyte and energy intake in critically ill adult patients." Thesis, Stellenbosch : Stellenbosch University, 2013. http://hdl.handle.net/10019.1/85659.
Full textENGLISH ABSTRACT: Objectives: The objectives of this study were to determine the nutritional content/ contribution of intravenous (IV) fluid and electrolyte administration on the total feeding prescription of intensive care unit (ICU) patients. Methods: Retrospective review of ICU charts of consecutive patients (>18 years) with APACHE II scores ≥10 and on ≥72 hours nutrition therapy (NT) admitted to a medical/surgical ICU. Total fluid, electrolyte, energy and macronutrient intake from nutritional and non-nutritional sources were reviewed from ICU admission until discharge, discontinuation of NT or death for ≤7 days. Energy and protein delivery were compared to calculated targets of 25.4 – 28.6kCal/kg and 1.3 – 1.5g/kg respectively. Summary statistics, correlation coefficients and appropriate analysis of variance were used to describe and analyse the data. Results: A total of 71 patients (49% male), average age 49.2 ± 17.1, average APACHE II score 21.0 ± 6.1, 68% medical and 32% surgical, were included. Fluid and nutrient intake were reviewed over a mean of 5.7 ± 1.1 days. Mean daily fluid delivery was 3.2 ± 0.6L. IV fluid therapy (IVFT) contributed 32.0 ± 12.0% to total fluid delivery (TFD), whereas IV drug administration, including fluids used for reconstitution and dilution purposes, contributed 20.7 ± 8.1% to TFD. Balanced electrolyte solutions (BES) were the crystalloid of choice, prescribed in 91.5% of patients with a mean daily volume (MDV) of 0.5 ± 0.4L. Hypertonic low molecular weight (LMW) 130/0.4kD hydroxyethyl starch (HES) was the colloid of choice, prescribed in 78.9% of patients with a MDV of 0.2 ± 0.1L. Potassium salts were the most frequently prescribed IV electrolyte supplement (IVES), prescribed in 91% of patients (±20 – 60mmol per administration). NT was initiated within 14.5 ± 14.1 hours. The majority (80%) received enteral nutrition (EN). The mean daily energy delivered was 1613 ± 380kCal (25.1kCal/kg), meeting 93.6 ± 17.7% of mean target range (MTR). Mean daily protein delivery (PD) was 72 ± 22g (1.1g/kg), meeting 82.8 ± 19.9% of MTR. Non-nutritional energy sources (NNES), mostly derived from carbohydrate-containing IV fluids, contributed 10.1 ± 7.5% to total energy delivered (156kCal/d). Mean cumulative energy and protein balance was -674.0 ± 1866.1kCal and -86.0 ± 106.9g respectively. The majority (73%) received >90% of the minimum energy target but only 49% >90% of minimum protein target; 59% of those with energy intake 90-110% of target had adequate protein intake. A significant negative correlation was found between cumulative energy/protein balance and the time to initiation of NT (energy: r=-0.28, p=0.02; protein: r=-0.32, p=0.01). Conclusion: In this ICU BES are the crystalloid of choice and hypertonic LMW 130/0.4kD HES the colloid of choice for IVFT. Potassium salts are the most frequently prescribed IVES. NNES added significantly to energy delivery and should be included in the calculation of feeding prescriptions to avoid the harmful effects of overfeeding. Early initiation of EN with conventional products which are energy rich is insufficient to achieve adequate PD. EN formulae with a more favorable nitrogen to non-protein energy ratio could help to optimise PD during the first week of ICU care.
AFRIKAANSE OPSOMMING: Doelwitte: Die doelwit van hierdie studie was om die voedingswaarde/ bydrae van intraveneuse (IV) vog en elektroliet toediening tot die totale voedings voorskrif van pasiënte in ‘n intensiewe sorg eenheid (ISE) te bepaal. Metodes: Retrospektiewe bestudering van die ISE kaarte van agtereenvolgende pasiënte (>18 jaar) opgeneem in ‘n mediese/chirurgie ISE en met APACHE II tellings ≥10 en ≥72 ure voedingsterapie (VT). Totale vog, elektroliet, energie en makronutriënt inname vanaf voedingsverwante en nie-voedingsverwante bronne is vanaf ISE opname tot en met ontslag, staking van VT of sterfte, vir ≤7 dae hersien. Energie en proteiën inname is vergelyk met berekende doelwitte van 25.4 – 28.6kKal/kg en 1.3 – 1.5g/kg onderskeidelik. Beskrywende statisitiek, korrelasie koeffisiënte en toepaslike analises van variansie is gebruik vir data analise. Resultate: 71 pasiënte (49% mans), gemiddelde ouderdom 49.2 ± 17.1, gemiddelde APACHE II telling 21.0 ± 6.1, 68% medies en 32% chirurgie, is ingesluit. Vog en voedingstof inname is hersien oor ‘n gemiddelde tydperk van 5.7 ± 1.1 dae. Gemiddelde vog inname was 3.2 ± 0.6L/dag. IV vog terapie (IVVT) het 32.0 ± 12.0% bygedra tot totale vog inname (TVI). IV medikasie toediening, insluitende die herkonstruksie en verwatering van medikasie, het 20.7 ± 8.1% bygedra tot TVI. Die mees voorgeskrewe kristalloiëd en kolloiëd vir IVVT was gebalanseerde elektroliet oplossings (GEO), voorgeskryf in 91.5% van pasiënte (gemiddeld 0.5 ± 0.4L/dag), en hipertoniese lae molekulêre gewig (LMG) 130/0.4kD hidroksie-etiel stysel (HES), voorgeskryf in 78.9% van pasiënte (gemiddeld 0.2 ± 0.1L/dag), onderskeidelik. Die mees voorgeskrewe IV elektroliet supplement was kalium soute, voorgeskryf in 91% van pasiënte (±20 – 60 mmol per toediening). VT is binne 14.5 ± 14.1 ure geinisieër. Die meerderheid (80%) het enterale voeding (EV) ontvang. Die gemiddelde daaglikse energie inname van 1613 ± 380kCal (25.1kKal/kg) het 93.6 ± 17.7% van die gemiddelde doelwit rykwydte (GDR) bereik. Die gemiddelde daaglikse proteiën inname van 72 ± 22g (1.1g/kg) het 82.8 ± 19.9% van die GDR bereik. Nie voedings-verwante energie bronne (NVEB), meestal vanaf koolhidraat-bevattende IV vloeistowwe, het 10.1 ± 7.5% tot totale energie inname (TEI) bygedra (156kKal/d). Die gemiddelde kumulatiewe energie en proteiën balans was -674.0 ± 1866.1kKal en -86.0 ± 106.9g onderskeidelik. Die meerderheid (73%) het >90% van die minimum energie doelwit (ED) bereik. Slegs 49% het >90% van die minimum proteiën doelwit (PD) bereik. Opsomming: Die kristalloiëd en kolloiëd van keuse vir IVT is GEO en hipertoniese LMG 130/0.4kD HES onderskeidelik. Kalium soute word mees algemeen voorgeskryf. NVEB dra beduidend by tot TEI en moet inaggeneem word tydens die berekening van voedingsvoorskrifte ten einde oorvoeding te voorkom. Vroeë inisiëring van EV met konvensionele energie-ryke EV produkte is onvoldoende om genoegsame proteiën inname te verseker. EV produkte met ‘n gunstiger stikstof tot nie-proteiën energie verhouding sal help om proteiën inname gedurende die eerste week van intensiewe sorg te optimaliseer.Slegs 59% van pasiënte met genoegsame energie inname (90-110% van ED) het hul minimum PD bereik. Daar was ‘n beduidende negatiewe korrelasie tussen kumulatiewe energie/proteiën balans en die tyd tot inisiëring van VT (energie: r=-0.28, p=0.02; proteiën: r=-0.32, p= 0.01).
Kwok, Ka-wai, and 郭嘉慧. "The use of warmed intravenous fluid in reducing hypothermia in patients after major surgery." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B44623616.
Full textJagga, Willem Marcelle. "Peri-operative use of synthetic intravenous fluid by peri-operative physicians in South Africa." Master's thesis, Faculty of Health Sciences, 2019. http://hdl.handle.net/11427/31481.
Full textBowen, Danny R. "Efficiency of the Thermal Jacket on the Delivered Temperature of Prewarmed Crystalloid Intravenous Fluid." VCU Scholars Compass, 1989. http://scholarscompass.vcu.edu/etd/4372.
Full textLopes, Marco A. F. "Hydration of Colonic Ingesta and Feces in Horses Fed Large Grain Meals or Treated with Enteral Fluid Therapy, Saline Cathartics and Intravenous Fluid Therapy." Diss., Virginia Tech, 2002. http://hdl.handle.net/10919/29338.
Full textPh. D.
Ramalho, Cláudia Sofia Agua. "Estudo comparativo entre diferentes vias de administração de fluidos em equinos : endovenosa, oral e rectal." Bachelor's thesis, Universidade Técnica de Lisboa. Faculdade de Medicina Veterinária, 2010. http://hdl.handle.net/10400.5/2598.
Full textA fluidoterapia é uma prática frequente em clínica de equinos, essencialmente em patologias capazes de induzir uma alteração hemodinâmica como em casos de choque endotoxémico. Em clínica de equinos as vias mais utilizadas são a intravenosa e a oral. A via intravenosa é a via de eleição quando é pretendido um efeito rápido, por haver deposição de fluido directamente na corrente sanguínea. É, no entanto, a mais dispendiosa. Pode também recorrer-se à via oral, menos invasiva e útil em impactações ou deslocamentos de cólon. A presença de refluxo enterogástrico ou diminuição da motilidade gastrointestinal são contra-indicação absoluta para esta via. O objectivo do presente estudo realizado neste trabalho é comparar os efeitos sistémicos da fluidoterapia oral, IV e rectal, para determinar se esta ultima é ou não uma alternativa viável à via oral. Um grupo de seis cavalos recebeu três sessões de fluidoterapia por vias de administração diferentes, com intervalo mínimo de cinco dias entre elas. Os parâmetros avaliados foram o hematócrito, a concentração de proteínas plasmáticas e a frequência cardíaca, medidos com intervalos de 15 minutos. Foi feita também uma avaliação subjectiva da quantidade de urina produzida e da frequência de defecação e consistência das fezes. A solução utilizada foi o NaCl 0,9 % para as três vias de administração. Nas vias oral e rectal foram administrados 4 litros com intervalo de 20 minutos durante os primeiros 80 minutos e 4 litros com intervalo de 30 minutos até perfazer os 40 litros. Na via intravenosa foi usada uma taxa de administração contínua e 5 litros/hora. Nas três vias utilizadas os valores de hematócrito diminuíram ao longo da experiência. Na via oral e na rectal as alterações foram semelhantes, enquanto que na via endovenosa a descida foi mais rápida e profunda. Não se verificaram alterações estatisticamente significativas na concentração de proteínas plasmáticas. A via rectal revelou-se uma via de hidratação eficaz e uma alternativa viável à via de administração oral.
ABSTRACT - Analogy between different methods of administrating fluids in horses: Intravenous, Enteric and Rectal. - Fluid Therapy is a regular practice in horse clinic, essentially regarding pathologies capable of inducing a hemodynamic change, as seen in cases of endotoxic shock. In horse clinic, the most recurring methods of fluid administration are the intravenous and the oral. The intravenous method is the favoured one when a fast effect is pretended, due to the direct deposition of fluid in the blood flow. However, it is the most expensive. The oral method may also be utilized, less invasive and useful for impactions or colon displacement. The presence of enterogastric reflux or the decrease of gastrointestinal motility is an absolute contraindication for the use of this method. The goal of the analysis carried out in this work is to compare the systemic effects of the oral, intravenous and rectal fluid therapy, in order to determine if the latter is a consistent alternative to the oral method. A group of six horses has received three sessions of fluid therapy using different methods, with a minimum time gap of five days in between. The evaluated parameters were the haematocrit, the concentration of plasma proteins and the heart-rate, measured every 15 minutes. A subjective evaluation has also been done of the amount of produced urine, the frequency of defecation and the consistency of the faeces. The solution applied was the NaCl 0,9 % for the three methods of administration. Regarding the oral and rectal methods, 4 litres were given with 20-minute intervals during the first 80 minutes and 4 litres with the 30-minute interval until completing the 40 litres. For the intravenous method, a continuous rate of administration was used and 5 litre per hour. In the three methods, the haematocrit values have decreased throughout the experience. In the oral and rectal method, the changes were similar, whereas the decrease was faster and deeper in the intravenous method. There have not been any statistically significant changes on the concentration of plasma proteins. The rectal method has been proved to be an effective hydration method and a viable alternative to the oral administration.
Mancha, Dora Alexandra Inácio. "Fluidoterapia entérica versus fluidoterapia endovenosa em casos de síndrome de abdómen agudo em equinos." Bachelor's thesis, Universidade Técnica de Lisboa. Faculdade de Medicina Veterinária, 2009. http://hdl.handle.net/10400.5/1266.
Full textO Síndrome de Abdómen Agudo é uma patologia muito frequentemente encontrada na prática clínica de equinos. A hidratação dos cavalos com dor abdominal aguda é extremamente importante. Por este motivo, a abordagem terapêutica médica destes animais inclui quase invariavelmente a administração de fluidos. O médico veterinário pode recorrer à fluidoterapia entérica e à fluidoterapia endovenosa para o tratamento destes animais, podendo utilizá-las isoladamente ou em conjunto. A elaboração de um plano de fluidoterapia, seja entérica e/ou endovenosa, deve ser baseada na alteração clínica apresentada pelo animal. Nos casos de maior gravidade, nos quais os pacientes se apresentam com um grau de desidratação moderado a grave, a administração de fluidos por via endovenosa é imprescindível. Nestes casos, e também de modo a diminuir os custos económicos associados à fluidoterapia endovenosa, a fluidoterapia entérica pode ser considerada como um complemento sempre que não se verifique a presença de refluxo enterogástrico. A presença de refluxo enterogástrico é indicadora de disfunção gastrointestinal grave associada com o comprometimento das funções de secreção e absorção do intestino ou com alterações de trânsito intestinal, e constitui uma contra-indicação absoluta para a administração de fluidos por via entérica. A fluidoterapia entérica deve ser reservada para os casos de SAA associados com alterações hidroelectrolíticas ligeiras. Esta via de administração de fluidos representa um método rápido e económico para promover a hidratação dos conteúdos intestinais. Recentemente têm vindo a surgir cada vez mais evidências da eficácia da administração de fluidos por via entérica em casos de obstruções simples de intestino grosso (impactações e deslocamentos de cólon maior). De facto, nos casos de impactações intestinais não complicadas, faz mais sentido promover a hidratação da ingesta através de fluidoterapia entérica, provocando assim efeitos mínimos ao nível da circulação sistémica. Apesar de não se poderem substituir uma à outra, estas duas formas de administração de fluidos são fundamentais na abordagem médica aos casos de SAA em equinos pela sua complementaridade.
ABSTRACT - Enteral Fluid Therapy versus Intravenous Fluid Therapy in Equine Acute Abdomen - The acute abdomen is a very common feature in equine practice. The hydration of the horse with acute abdominal pain is extremely important, thus the treatment of these animals includes very often fluids administration. The equine practitioner can use enteral fluid therapy or intravenous fluid therapy alone or together for acute abdominal pain treatment. The fluid plan elaboration, whether enteral and/or intravenous, should be based on the animal clinical condition. In more serious cases the intravenous fluids administration is essential. Also in these cases, to reduce the costs associated to intravenous fluid therapy, enteral fluids can be used as a complement when there is no gastric reflux, which indicates a serious gastrointestinal dysfunction associated with motility disorders or impaired intestinal absorption and secretion mechanisms. So, gastric reflux is an absolute contraindication for the use of enteral fluids. The enteral fluid therapy should be reserved for acute abdomen cases associated with mild hydroelectrolyte disorders. The administration of enteral fluids represents a quick and economical method to promote the hydration of intestinal contents. There are some recent scientific reports that support the efficacy of enteral fluid therapy in mild cases of large intestinal obstruction (impactions and displacements). In fact, in uncomplicated impactions, it makes more physiological sense to promote direct ingesta hydration while having minimal effects on the systemic circulation. Although one can not replace the other, these fluid administration routes are essential and complementar in the medical management of equine acute abdomen cases.
Books on the topic "Intravenous fluid"
Phillips, Lynn Dianne. Manual of intravenous therapeutics. Philadelphia: F.A. Davis, 1993.
Find full textHahn, Robert G. Intravenous fluids in anaesthetic practice. Edited by Michel M. R. F. Struys. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199642045.003.0020.
Full textWijdicks, Eelco F. M., and Sarah L. Clark. Fluid Therapy. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190684747.003.0014.
Full textInc, Medical Data International, ed. U.S. market for drug & i.v. fluid delivery devices & supplies. Irvine, Calif. (2 Park Plaza, Suite 750, Irvine 92714): Medical Data International, 1995.
Find full text(Editor), Ann Corrigan, Gloria Pelletier (Editor), and Mary Alexander (Editor), eds. Core Curriculum for Intravenous Nursing (Books). 2nd ed. Lippincott Williams & Wilkins, 1999.
Find full textJ, Turner, and National Co-ordinating Centre for HTA (Great Britain), eds. A Randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. Alton: Core Research on behalf of the NCCHTA, 2000.
Find full textCompany, Market Intelligence Research, ed. Technological developments lead fluid and drug delivery systems market. Mountain View, CA, USA (2525 Charleston Rd., Mountain View 94043): Market Intelligence Research Co., 1990.
Find full textInc, Medical Data International, ed. U.S. markets for I.V. fluid and drug delivery devices. Irvine, Calif. (2 Park Plaza, Suite 1200, Irvine 92614): Medical Data International, 1998.
Find full textHahn, Robert G. Fluid and electrolyte physiology in anaesthetic practice. Edited by Jonathan G. Hardman. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199642045.003.0003.
Full textBook chapters on the topic "Intravenous fluid"
Corbett, Eugene C. "Intravenous Fluid Administration." In Geriatric Gastroenterology, 153–59. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-1623-5_17.
Full textCorbett, Eugene C., and T. S. Dharmarajan. "Intravenous Fluid Administration." In Geriatric Gastroenterology, 1–13. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-90761-1_19-1.
Full textCorbett, Eugene C., and T. S. Dharmarajan. "Intravenous Fluid Administration." In Geriatric Gastroenterology, 555–67. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-30192-7_19.
Full textKelava, Marta, David S. Youssef, and Maged Argalious. "Perioperative Intravenous Fluid Therapy." In Basic Sciences in Anesthesia, 259–67. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-62067-1_15.
Full textSouthwood, Louise L. "Intravenous Catheterization and Fluid Therapy." In Practical Guide to Equine Colic, 99–115. West Sussex, UK: John Wiley & Sons, Inc,., 2013. http://dx.doi.org/10.1002/9781118704783.ch11.
Full textWendt-Hornickle, Erin. "Intravenous Access and Fluid Administration." In Questions and Answers in Small Animal Anesthesia, 65–72. Hoboken, NJ, USA: John Wiley & Sons, Inc, 2015. http://dx.doi.org/10.1002/9781118912997.ch9.
Full textAldridge, Paul, and Louise O'Dwyer. "‘Shock' and Intravenous Fluid Therapy." In Practical Emergency and Critical Care Veterinary Nursing, 29–40. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118782873.ch4.
Full textSangeetha, K., P. Vishnuraja, S. Dinesh, V. S. Gokul Anandh, and K. Hariprakash. "Intravenous Fluid Monitoring System Using IoT." In Mobile Computing and Sustainable Informatics, 863–71. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-1866-6_66.
Full textReddi, Alluru S. "Intravenous Fluids: Composition and Indications." In Fluid, Electrolyte and Acid-Base Disorders, 33–44. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-9083-8_4.
Full textReddi, Alluru S. "Intravenous Fluids: Composition and Indications." In Fluid, Electrolyte and Acid-Base Disorders, 35–49. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-60167-0_4.
Full textConference papers on the topic "Intravenous fluid"
Bhavasaar, Monisha K., M. Nithya, R. Praveena, N. S. Bhuvaneswari, and T. Kalaiselvi. "Automated intravenous fluid monitoring and alerting system." In 2016 IEEE Technological Innovations in ICT for Agriculture and Rural Development (TIAR). IEEE, 2016. http://dx.doi.org/10.1109/tiar.2016.7801217.
Full textEvans, S., R. Mills, and T. Ninan. "G138(P) Acute bronchiolitis: variations in intravenous fluid administration." In Royal College of Paediatrics and Child Health, Abstracts of the Annual Conference, 13–15 March 2018, SEC, Glasgow, Children First – Ethics, Morality and Advocacy in Childhood, The Journal of the Royal College of Paediatrics and Child Health. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2018. http://dx.doi.org/10.1136/archdischild-2018-rcpch.134.
Full textGabriel, Joseph M., Takatoshi Kasai, Luigi Taranto Montemurro, Fiona Rankin, Hisham Alshaer, John Floras, Alexander G. Logan, and Douglas Bradley. "Intravenous Fluid Loading During Sleep Induces Upper Airway Narrowing." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2437.
Full text"Assessment of Intravenous Fluid Delivery Systems for a Microgravity Environment." In 55th International Astronautical Congress of the International Astronautical Federation, the International Academy of Astronautics, and the International Institute of Space Law. Reston, Virigina: American Institute of Aeronautics and Astronautics, 2004. http://dx.doi.org/10.2514/6.iac-04-g.2.11.
Full textHuda, AU. "ESRA19-0078 Intravenous fluid therapy and its compliance with nice guideline." In Abstracts of the European Society of Regional Anesthesia, September 11–14, 2019. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/rapm-2019-esraabs2019.288.
Full textKing, S. I., S. McMurtry, J. A. Hippensteel, and E. P. Schmidt. "Determining the Mechanisms Responsible for Intravenous Fluid-Associated Endothelial Glycocalyx Degradation." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3623.
Full textChhoan, Anisha Parsub, Sumit Sarker, and Dabasish Kumar Saha. "A Low-Cost Automatic Intravenous Fluid Control System for Medical Treatment." In 2020 2nd International Conference on Advanced Information and Communication Technology (ICAICT). IEEE, 2020. http://dx.doi.org/10.1109/icaict51780.2020.9333457.
Full textMcGuinness, Shay, Rachael L. Parke, Eileen Gilder, and Jodi Brown. "Intravenous Fluid Use Following Cardiac Surgery: A Single Centre Prospective Observational Study." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6011.
Full textWuyts, S., P. Van Landuyt, PJ Cortoos, and P. Cornu. "5PSQ-133 Evaluation of a quality monitoring programme for intravenous fluid management." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.252.
Full textShaunak, M., and S. Tibby. "G156(P) Risk factors for excessive intravenous fluid prescription in children with diabetic ketoacidosis." In Royal College of Paediatrics and Child Health, Abstracts of the Annual Conference, 24–26 May 2017, ICC, Birmingham. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2017. http://dx.doi.org/10.1136/archdischild-2017-313087.155.
Full text